Maintenance Therapy with Intravesical Bacillus Calmette-Guérin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer

By Muto Satoru   Nakajima Akiko   Horiuchi Akira   Inoue Masayuki   China Toshiyuki   Saito Keisuke   Isotani Shuji   Hisasue Shin-ichi   Yamaguchi Raizo   Ide Hisamitsu   Horie Shigeo  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 3, 2013-03 ,pp. : 305-313

Oxford University Press

Access to resources Recommend Favorite

Monthly intravesical bacillus Calmette-Guérin maintenance therapy for non-muscle-invasive bladder cancer: 10-year experience in a single institute

By      

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 221-225

Spandidos Publications

Access to resources Recommend Favorite

Prediction of response to bacillus Calmette-Guérin treatment in non-muscle invasive bladder cancer patients through interleukin-6 and interleukin-10 ratio

By                  

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 459-464

Spandidos Publications

Access to resources Recommend Favorite

Tumor Multiplicity Is an Independent Prognostic Factor of Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guerin Immunotherapy

By Ajili Faouzia   Manai Mohamed   Darouiche Amine   Chebil Mohamed   Boubaker Samir  

Ultrastructural Pathology, Vol. 36, Iss. 5, 2012-10 ,pp. : 320-324

Informa Healthcare

Access to resources Recommend Favorite

The Impact of Age and Clinical Factors in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette Guerin Therapy

By Ajili Faouzia  

Ultrastructural Pathology, Vol. 37, Iss. 3, 2013-05 ,pp. : 191-195

Informa Healthcare

Access to resources Recommend Favorite